255 related articles for article (PubMed ID: 21048442)
1. Fertility preservation in women with breast cancer.
Rodriguez-Wallberg KA; Oktay K
Clin Obstet Gynecol; 2010 Dec; 53(4):753-62. PubMed ID: 21048442
[TBL] [Abstract][Full Text] [Related]
2. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study.
Azim AA; Costantini-Ferrando M; Oktay K
J Clin Oncol; 2008 Jun; 26(16):2630-5. PubMed ID: 18509175
[TBL] [Abstract][Full Text] [Related]
3. Fertility preservation options in breast cancer patients.
Kasum M; von Wolff M; Franulić D; Čehić E; Klepac-Pulanić T; Orešković S; Juras J
Gynecol Endocrinol; 2015; 31(11):846-51. PubMed ID: 26370157
[TBL] [Abstract][Full Text] [Related]
4. Concomitant tamoxifen or letrozole for optimal oocyte yield during fertility preservation for breast cancer: the TAmoxifen or Letrozole in Estrogen Sensitive tumors (TALES) randomized clinical trial.
Letourneau J; Juarez-Hernandez F; Wald K; Ribeiro S; Wang A; McCulloch CE; Mok-Lin E; Dolezal M; Chien AJ; Cedars MI; Rosen M
J Assist Reprod Genet; 2021 Sep; 38(9):2455-2463. PubMed ID: 34312774
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen or letrozole versus standard methods for women with estrogen-receptor positive breast cancer undergoing oocyte or embryo cryopreservation in assisted reproduction.
Dahhan T; Balkenende E; van Wely M; Linn S; Goddijn M
Cochrane Database Syst Rev; 2013 Nov; (11):CD010240. PubMed ID: 24213953
[TBL] [Abstract][Full Text] [Related]
6. Is letrozole needed for controlled ovarian stimulation in patients with estrogen receptor-positive breast cancer?
Revelli A; Porcu E; Levi Setti PE; Delle Piane L; Merlo DF; Anserini P
Gynecol Endocrinol; 2013 Nov; 29(11):993-6. PubMed ID: 24000936
[TBL] [Abstract][Full Text] [Related]
7. Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation.
Oktay K
J Clin Oncol; 2005 Jun; 23(16):3858-9. PubMed ID: 15911867
[No Abstract] [Full Text] [Related]
8. Stimulation of the ovaries in women with breast cancer undergoing fertility preservation: Alternative versus standard stimulation protocols; the study protocol of the STIM-trial.
Dahhan T; Balkenende EME; Beerendonk CCM; Fleischer K; Stoop D; Bos AME; Lambalk CB; Schats R; van Golde RJT; Schipper I; Louwé LA; Cantineau AEP; Smeenk JMJ; de Bruin JP; Reddy N; Kopeika Y; van der Veen F; van Wely M; Linn SC; Goddijn M
Contemp Clin Trials; 2017 Oct; 61():96-100. PubMed ID: 28710053
[TBL] [Abstract][Full Text] [Related]
9. Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients.
Turan V; Bedoschi G; Moy F; Oktay K
Fertil Steril; 2013 Dec; 100(6):1681-5.e1. PubMed ID: 24055050
[TBL] [Abstract][Full Text] [Related]
10. [Fertility preservation in breast cancer patients by embryo cryopreservation after ovarian stimulation with letrozole and FSH].
Beckmann MW; Findeklee S
Strahlenther Onkol; 2015 Nov; 191(11):895-6. PubMed ID: 26400478
[No Abstract] [Full Text] [Related]
11. Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients.
Goldrat O; Gervy C; Englert Y; Delbaere A; Demeestere I
Hum Reprod; 2015 Sep; 30(9):2184-9. PubMed ID: 26109617
[TBL] [Abstract][Full Text] [Related]
12. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation.
Oktay K; Buyuk E; Libertella N; Akar M; Rosenwaks Z
J Clin Oncol; 2005 Jul; 23(19):4347-53. PubMed ID: 15824416
[TBL] [Abstract][Full Text] [Related]
13. The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review.
Rodgers RJ; Reid GD; Koch J; Deans R; Ledger WL; Friedlander M; Gilchrist RB; Walters KA; Abbott JA
Hum Reprod; 2017 May; 32(5):1033-1045. PubMed ID: 28333356
[TBL] [Abstract][Full Text] [Related]
14. Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles.
Sönmezer M; Türkçüoğlu I; Coşkun U; Oktay K
Fertil Steril; 2011 May; 95(6):2125.e9-11. PubMed ID: 21292255
[TBL] [Abstract][Full Text] [Related]
15. The case for aromatase inhibitors use in oncofertility patients. Should aromatase inhibitors be combined with gonadotropin treatment in breast cancer patients undergoing ovarian stimulation for fertility preservation prior to chemotherapy? A debate.
Fatum M; McVeigh E; Child T
Hum Fertil (Camb); 2013 Dec; 16(4):235-40. PubMed ID: 23863119
[TBL] [Abstract][Full Text] [Related]
16. Fertility Preservation Success Subsequent to Concurrent Aromatase Inhibitor Treatment and Ovarian Stimulation in Women With Breast Cancer.
Oktay K; Turan V; Bedoschi G; Pacheco FS; Moy F
J Clin Oncol; 2015 Aug; 33(22):2424-9. PubMed ID: 26101247
[TBL] [Abstract][Full Text] [Related]
17. The impact of letrozole administration on oocyte morphology in breast cancer patients undergoing fertility preservation.
Bercaire LMN; Cavagna M; Donadio NF; Rocha AR; Portela R; Alves VR; Santos TBB; Cavagna F; Dzik A; Gebrim LH; Nahas EAP
JBRA Assist Reprod; 2020 Jul; 24(3):257-264. PubMed ID: 32293820
[TBL] [Abstract][Full Text] [Related]
18. Comparison of ovarian stimulation response in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins to patients undergoing ovarian stimulation with gonadotropins alone for elective cryopreservation of oocytes†.
Pereira N; Hancock K; Cordeiro CN; Lekovich JP; Schattman GL; Rosenwaks Z
Gynecol Endocrinol; 2016 Oct; 32(10):823-826. PubMed ID: 27114051
[TBL] [Abstract][Full Text] [Related]
19. Effects of letrozole or tamoxifen coadministered with a standard stimulation protocol on fertility preservation among breast cancer patients.
Shulman Y; Almog B; Kalma Y; Fouks Y; Azem F; Cohen Y
J Assist Reprod Genet; 2021 Mar; 38(3):743-750. PubMed ID: 33409757
[TBL] [Abstract][Full Text] [Related]
20. Random-start ovarian stimulation in patients with cancer.
Cakmak H; Rosen MP
Curr Opin Obstet Gynecol; 2015 Jun; 27(3):215-21. PubMed ID: 25919235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
